Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 15%
Buy 54%
Hold 23%
Sell 0%
Strong Sell 8%

Bulls say

Intuitive Surgical has demonstrated positive operational growth, with a 14% increase in Ion utilization and a 35% increase in SP utilization, further enhancing its overall installed base to 954 and 345 systems, respectively. The improved performance is complemented by a better-than-expected increase in US Da Vinci utilization, rising approximately 2% year-over-year, attributed to the higher performance of the newer D5 models. Additionally, the company has raised its gross margin guidance to 67-67.5%, indicating strong financial health driven by increased system placements and a favorable outlook on tariffs.

Bears say

The financial outlook for Intuitive Surgical appears negative due to several key factors impacting its operational and market performance. Revenue from services slightly missed expectations at $396 million, which reflects broader industry challenges such as hospital capital budget constraints and macroeconomic uncertainty that are leading to deferred purchasing decisions for robotic systems. Furthermore, the company faces resistance to adopting its newer robotic platforms in emerging markets, alongside pressure on instrument and accessories pricing driven by third-party instrument reprocessing, contributing to a less favorable operational environment.

Intuitive Surgical (ISRG) has been analyzed by 13 analysts, with a consensus rating of Buy. 15% of analysts recommend a Strong Buy, 54% recommend Buy, 23% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 13 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Jan 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $593.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $593.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.